Open AccessSAT-099 Liraglutide 3.0 mg as an Adjunct to Intensive Behavior Therapy in Individuals with Obesity: SCALE IBT 56-Week Randomized, Double-Blind, Placebo-Controlled Trial
Author(s) -
Thomas A. Wadden,
Jena Shaw Tronieri,
Daniel Sugimoto,
Marie Lund,
Pernille Auerbach,
Camilla Jensen,
Domenica Rubino
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-099
Subject(s) - liraglutide , medicine , placebo , body mass index , clinical endpoint , tolerability , randomized controlled trial , weight loss , intention to treat analysis , physical therapy , obesity , adverse effect , type 2 diabetes , diabetes mellitus , endocrinology , alternative medicine , pathology